{"@type": "dcat:Dataset", "accessLevel": "public", "bureauCode": ["009:25"], "contactPoint": {"@type": "vcard:Contact", "fn": "NIH/NCBI Data Team", "hasEmail": "mailto:info@ncbi.nlm.nih.gov"}, "description": "This invention relates to processes for preparing derivatives of 3,6-disubstituted azabicyclo compounds that can function as muscarinic receptor antagonists, and can be used for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors.", "distribution": [{"@type": "dcat:Distribution", "description": "Access the complete Patent AT-E400553-T1: [Translated] 3,6-DISUBSTITUTED AZABICYCLO 3.1.0 - HEXANE DERIVATIVES AS ANTAGONISTS OF THE MUSCARINE RECEPTOR on the official website.", "downloadURL": "https://pubchem.ncbi.nlm.nih.gov/patent/AT-E400553-T1", "mediaType": "text/html", "title": "Official Data Source"}], "identifier": "https://healthdata.gov/api/views/99v5-vude", "issued": "2025-09-05", "keyword": ["chemistry", "innovation", "patent", "pubchem", "research"], "landingPage": "https://healthdata.gov/d/99v5-vude", "modified": "2025-09-06", "programCode": ["009:066"], "publisher": {"@type": "org:Organization", "name": "National Center for Biotechnology Information (NCBI)"}, "theme": ["NIH"], "title": "Patent AT-E400553-T1: [Translated] 3,6-DISUBSTITUTED AZABICYCLO 3.1.0 - HEXANE DERIVATIVES AS ANTAGONISTS OF THE MUSCARINE RECEPTOR"}